Crossmark

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics

Crossref DOI link: https://doi.org/10.1186/s40478-018-0577-2

Published Online: 2018-08-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

den Haan, Jurre http://orcid.org/0000-0003-1476-5568
Morrema, Tjado H. J.

Rozemuller, Annemieke J.

Bouwman, Femke H.

Hoozemans, Jeroen J. M.
Funding

Funding for this research was provided by:

Alzheimer Nederland
License Information

Text and Data Mining valid from 2018-08-09
More Information

Article History

Received: 21 June 2018

Accepted: 27 July 2018

First Online: 9 August 2018

Ethics approval and consent to participate

: Prior to death, donors signed informed consent with the Netherlands Brain Bank (NBB) for brain autopsy and use of brain tissue and medical records for research purposes.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.